BarakatLP, SchwartzLA, ReillyA, et al. A qualitative study of phase III cancer clinical trial enrollment decision-making: perspectives from adolescents, young adults, caregivers, and providers. J Adolesc Young Adult Oncol., 2014; 3(1):3–11.
2.
BirchRJ, MorrisEJA, StarkDP, et al. Geographical factors affecting the admission of teenagers and young adults to age-specialist inpatient cancer care in England. J Adolesc Young Adult Oncol., 2014; 3(1):28–36.
3.
GrigsbyTJ, KentEE, MontoyaMJ, et al. Attitudes toward cancer clinical trial participation in young adults with a history of cancer and a healthy college student sample: a preliminary investigation. J Adolesc Young Adult Oncol., 2014; 3(1):20–27.
4.
FarberS, DiamondLK, MercerRD, et al. Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid (aminopterin). N Engl J Med., 1948; 238(23):787–93.
5.
FernLA, WhelanJS. Recruitment of adolescents and young adults to cancer clinical trials—international comparisons, barriers, and implications. Semin Oncol., 2010; 37(2):e1–8.
6.
BleyerA, BuddT, MontelloM. Adolescents and young adults with cancer: the scope of the problem and criticality of clinical trials. Cancer. 2006 Oct, 1; 107(7 Suppl):1645–55.
